Transform patient experience with intelligent hyper-personalisationSince 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and Share XTransform patient experience with intelligent hyper-personalisationhttps://pharmaphorum.com/whitepapers/patient-experience-personalisation-indegene/
Indegene gains $200m backing for expansion plansIndegene has struck a deal with two investment companies that will see them take a $200 million minority Share XIndegene gains $200m backing for expansion planshttps://pharmaphorum.com/news/indegene-investment-expansion/
Providing a positive customer experience through pharma contentCustomers must be given positive, trustworthy, and relevant experiences, says Indegene’s Martin O’Brien. Content is playing an increasingly Share XProviding a positive customer experience through pharma contenthttps://pharmaphorum.com/views-analysis-sales-marketing/providing-a-positive-customer-experience-through-pharma-content/
Customer experience in healthcare – a strategic priority for pharmaCustomer experience (CX) is widely, and rightly, acknowledged to be one of the pharmaceutical industry’s top strategic priorities. Share XCustomer experience in healthcare – a strategic priority for pharmahttps://pharmaphorum.com/whitepapers/customer-experience-strategy-healthcare-pharma/
Engaging with customers in a digital worldAs part of our series on customer experience in pharma, in partnership with Indegene, Ipsen’s Paul Murasko explains Share XEngaging with customers in a digital worldhttps://pharmaphorum.com/views-analysis-digital/engaging-with-customers-in-a-digital-world/
Customer experience in pharma: Getting the journey rightAs part of a series of interviews in partnership with Indegene focusing on the customer experience in pharma, Share XCustomer experience in pharma: Getting the journey righthttps://pharmaphorum.com/views-analysis-sales-marketing/customer-experience-in-pharma-getting-the-journey-right/
Syneos Health invests in Microsoft/Indegene platformBiopharma services company Syneos Health has taken a minority stake in Indegene Omnipresence, a partnership between life sciences Share XSyneos Health invests in Microsoft/Indegene platformhttps://pharmaphorum.com/news/syneos-health-microsoft-indegene-life-sciences-platform/
Reimagining commercialisation with AIWe speak to Indegene’s Gaurav Kapoor to find out how he thinks pharma’s sales and marketing model needs Share XReimagining commercialisation with AIhttps://pharmaphorum.com/views-analysis-digital/reimagining-commercialisation-with-ai/
Remote HCP engagement – still a struggle for life science companiesLife science companies are failing to achieve their full digital potential, particularly when it comes to the use Share XRemote HCP engagement – still a struggle for life science companieshttps://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/
